Penn State Health Children's Hospital is a nationally ranked women's and pediatric acute care teaching hospital located in Hershey, Pennsylvania. The hospital has 134 pediatric beds. PSCH is affiliated with the Penn State College of Medicine and is located at the Milton S. Hershey Medical Center.

There are 134 beds in Penn State Children's Hospital.

During the past decade, Penn State Children's Hospital conducted 71 clinical trials. In the 10-year time frame, 71 clinical trials started and 79 clinical trials were completed, i.e. on average, 111.3% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 33 clinical trials were completed. i.e. 91.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Penn State Children's Hospital" #1 sponsor was "Children's Oncology Group" with 85 trials, followed by "National Cancer Institute (NCI)" with 32 trials sponsored, "Wake Forest University Health Sciences" with 8 trials sponsored, "Milton S. Hershey Medical Center" with 4 trials sponsored and "Bristol-Myers Squibb" with 4 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 41 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Penn State Children's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 88 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 5 trials as a collaborator, "Beat NB Cancer Foundation" with 4 trials as a collaborator, "Children's Hospital Medical Center, Cincinnati" with 4 trials as a collaborator and "Arkansas Children's Hospital Research Institute" with 3 trials as a collaborator. Other collaborators include 142 different institutions and companies that were collaborators in the rest 123 trials.

According to Clinical.Site data, the most researched conditions in "Penn State Children's Hospital" are "Neuroblastoma" (15 trials), "Acute Lymphoblastic Leukemia" (9 trials), "Recurrent Neuroblastoma" (8 trials), "Medulloblastoma" (7 trials) and "Adult Rhabdomyosarcoma" (6 trials). Many other conditions were trialed in "Penn State Children's Hospital" in a lesser frequency.

Most popular intervention types in "Penn State Children's Hospital" are "Drug" (126 trials), "Other" (85 trials), "Biological" (51 trials), "Procedure" (46 trials) and "Radiation" (42 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (45 trials), "Cyclophosphamide" (40 trials), "Vincristine Sulfate" (34 trials), "Etoposide" (27 trials) and "Doxorubicin Hydrochloride" (24 trials). Other intervention names were less common.

The vast majority of trials in "Penn State Children's Hospital" are 169 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Penn State Children's Hospital". undefined are not yet recruiting, 46 are recruiting, 45 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 69 completed trials in Penn State Children's Hospital, 1 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Penn State Children's Hospital, 13 "Phase 1" clinical trials were conducted, 52 "Phase 2" clinical trials and 74 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 10 trials that are defined as “Not Applicable".